Form 483

Miguelangelo J. Perez-Cruet, M.D., M.S. Form 483, 2009-12-02

FDA issued a Form 483 to Miguelangelo J. Perez-Cruet, M.D., M.S. on 2009-12-02 with 7 public-safe observations.

483· Form 483 issued7 observations

Miguelangelo J. Perez-Cruet, M.D., M.S. · Waterford Township, United States · Issued December 2, 2009

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Dec 2009
21 CFR 50.20

Consent not obtained, exceptions do not apply

Cited by Barbara A Rusin

2 Dec 2009
21 CFR 50.27(a)

Consent form not approved/signed/dated

Cited by Barbara A Rusin

2 Dec 2009
21 CFR 812.36(e)

No IRB approval for treatment use

Cited by Barbara A Rusin

2 Dec 2009
21 CFR 812.110(b)

Investigator non-compliance with agreement/plan/regulations

Cited by Barbara A Rusin

2 Dec 2009
21 CFR 812.110(d)

Inadequate financial disclosure by investigator

Cited by Barbara A Rusin

Inspected site

MJMiguelangelo J. Perez-Cruet, M.D., M.S.Waterford Township, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 50.20Cited across public-safe Form 483 observations1x
21 CFR 50.27(a)Cited across public-safe Form 483 observations1x
21 CFR 812.110(b)Cited across public-safe Form 483 observations1x
21 CFR 812.110(d)Cited across public-safe Form 483 observations1x
21 CFR 812.140(a)(3)(ii)Cited across public-safe Form 483 observations1x
21 CFR 812.150(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 812.36(e)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 7 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere